190 related articles for article (PubMed ID: 37122218)
1. Generation of cardiomyocytes from human-induced pluripotent stem cells resembling atrial cells with ability to respond to adrenoceptor agonists.
Ahmad FS; Jin Y; Grassam-Rowe A; Zhou Y; Yuan M; Fan X; Zhou R; Mu-U-Min R; O'Shea C; Ibrahim AM; Hyder W; Aguib Y; Yacoub M; Pavlovic D; Zhang Y; Tan X; Lei M; Terrar DA
Philos Trans R Soc Lond B Biol Sci; 2023 Jun; 378(1879):20220312. PubMed ID: 37122218
[TBL] [Abstract][Full Text] [Related]
2. Human iPSC modelling of a familial form of atrial fibrillation reveals a gain of function of If and ICaL in patient-derived cardiomyocytes.
Benzoni P; Campostrini G; Landi S; Bertini V; Marchina E; Iascone M; Ahlberg G; Olesen MS; Crescini E; Mora C; Bisleri G; Muneretto C; Ronca R; Presta M; Poliani PL; Piovani G; Verardi R; Di Pasquale E; Consiglio A; Raya A; Torre E; Lodrini AM; Milanesi R; Rocchetti M; Baruscotti M; DiFrancesco D; Memo M; Barbuti A; Dell'Era P
Cardiovasc Res; 2020 May; 116(6):1147-1160. PubMed ID: 31504264
[TBL] [Abstract][Full Text] [Related]
3. Development of a robust induced pluripotent stem cell atrial cardiomyocyte differentiation protocol to model atrial arrhythmia.
Thorpe J; Perry MD; Contreras O; Hurley E; Parker G; Harvey RP; Hill AP; Vandenberg JI
Stem Cell Res Ther; 2023 Jul; 14(1):183. PubMed ID: 37501071
[TBL] [Abstract][Full Text] [Related]
4. Biophysical properties of Na
Chapotte-Baldacci CA; Pierre M; Djemai M; Pouliot V; Chahine M
Sci Rep; 2023 Nov; 13(1):20685. PubMed ID: 38001331
[TBL] [Abstract][Full Text] [Related]
5. Bioengineering approaches to mature induced pluripotent stem cell-derived atrial cardiomyocytes to model atrial fibrillation.
Ly OT; Brown GE; Han YD; Darbar D; Khetani SR
Exp Biol Med (Maywood); 2021 Aug; 246(16):1816-1828. PubMed ID: 33899540
[TBL] [Abstract][Full Text] [Related]
6. Atrial-like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial-selective pharmacology.
Devalla HD; Schwach V; Ford JW; Milnes JT; El-Haou S; Jackson C; Gkatzis K; Elliott DA; Chuva de Sousa Lopes SM; Mummery CL; Verkerk AO; Passier R
EMBO Mol Med; 2015 Apr; 7(4):394-410. PubMed ID: 25700171
[TBL] [Abstract][Full Text] [Related]
7. Intermittent Optogenetic Tachypacing of Atrial Engineered Heart Tissue Induces Only Limited Electrical Remodelling.
Lemoine MD; Lemme M; Ulmer BM; Braren I; Krasemann S; Hansen A; Kirchhof P; Meyer C; Eschenhagen T; Christ T
J Cardiovasc Pharmacol; 2020 Dec; 77(3):291-299. PubMed ID: 33278190
[TBL] [Abstract][Full Text] [Related]
8. Mutant ANP induces mitochondrial and ion channel remodeling in a human iPSC-derived atrial fibrillation model.
Ly OT; Chen H; Brown GE; Hong L; Wang X; Han YD; Pavel MA; Sridhar A; Maienschein-Cline M; Chalazan B; Ong SG; Abdelhady K; Massad M; Rizkallah LE; Rehman J; Khetani SR; Darbar D
JCI Insight; 2022 Apr; 7(7):. PubMed ID: 35393944
[TBL] [Abstract][Full Text] [Related]
9. Electrophysiologic Characterization of Calcium Handling in Human Induced Pluripotent Stem Cell-Derived Atrial Cardiomyocytes.
Argenziano M; Lambers E; Hong L; Sridhar A; Zhang M; Chalazan B; Menon A; Savio-Galimberti E; Wu JC; Rehman J; Darbar D
Stem Cell Reports; 2018 Jun; 10(6):1867-1878. PubMed ID: 29731429
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts.
Streckfuss-Bömeke K; Wolf F; Azizian A; Stauske M; Tiburcy M; Wagner S; Hübscher D; Dressel R; Chen S; Jende J; Wulf G; Lorenz V; Schön MP; Maier LS; Zimmermann WH; Hasenfuss G; Guan K
Eur Heart J; 2013 Sep; 34(33):2618-29. PubMed ID: 22798560
[TBL] [Abstract][Full Text] [Related]
11. Atrial-specific hiPSC-derived cardiomyocytes in drug discovery and disease modeling.
Gharanei M; Shafaattalab S; Sangha S; Gunawan M; Laksman Z; Hove-Madsen L; Tibbits GF
Methods; 2022 Jul; 203():364-377. PubMed ID: 34144175
[TBL] [Abstract][Full Text] [Related]
12. Generation of functional murine cardiac myocytes from induced pluripotent stem cells.
Mauritz C; Schwanke K; Reppel M; Neef S; Katsirntaki K; Maier LS; Nguemo F; Menke S; Haustein M; Hescheler J; Hasenfuss G; Martin U
Circulation; 2008 Jul; 118(5):507-17. PubMed ID: 18625890
[TBL] [Abstract][Full Text] [Related]
13. Ultrarapid Delayed Rectifier K
Hilderink S; Devalla HD; Bosch L; Wilders R; Verkerk AO
Front Cell Dev Biol; 2020; 8():536. PubMed ID: 32850774
[TBL] [Abstract][Full Text] [Related]
14. Human Cardiomyocytes Prior to Birth by Integration-Free Reprogramming of Amniotic Fluid Cells.
Jiang G; Herron TJ; Di Bernardo J; Walker KA; O'Shea KS; Kunisaki SM
Stem Cells Transl Med; 2016 Dec; 5(12):1595-1606. PubMed ID: 27465073
[TBL] [Abstract][Full Text] [Related]
15. Calcium homeostasis in human induced pluripotent stem cell-derived cardiomyocytes.
Lee YK; Ng KM; Lai WH; Chan YC; Lau YM; Lian Q; Tse HF; Siu CW
Stem Cell Rev Rep; 2011 Nov; 7(4):976-86. PubMed ID: 21614516
[TBL] [Abstract][Full Text] [Related]
16. High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents.
Ma J; Guo L; Fiene SJ; Anson BD; Thomson JA; Kamp TJ; Kolaja KL; Swanson BJ; January CT
Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H2006-17. PubMed ID: 21890694
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis of downregulation of G-protein-coupled inward rectifying K(+) current (I(K,ACh) in chronic human atrial fibrillation: decrease in GIRK4 mRNA correlates with reduced I(K,ACh) and muscarinic receptor-mediated shortening of action potentials.
Dobrev D; Graf E; Wettwer E; Himmel HM; Hála O; Doerfel C; Christ T; Schüler S; Ravens U
Circulation; 2001 Nov; 104(21):2551-7. PubMed ID: 11714649
[TBL] [Abstract][Full Text] [Related]
18. Ion Channel Expression and Electrophysiology of Singular Human (Primary and Induced Pluripotent Stem Cell-Derived) Cardiomyocytes.
Schmid C; Abi-Gerges N; Leitner MG; Zellner D; Rast G
Cells; 2021 Nov; 10(12):. PubMed ID: 34943878
[TBL] [Abstract][Full Text] [Related]
19. Deep phenotyping of human induced pluripotent stem cell-derived atrial and ventricular cardiomyocytes.
Cyganek L; Tiburcy M; Sekeres K; Gerstenberg K; Bohnenberger H; Lenz C; Henze S; Stauske M; Salinas G; Zimmermann WH; Hasenfuss G; Guan K
JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925689
[TBL] [Abstract][Full Text] [Related]
20. Human induced pluripotent stem cell-derived atrial cardiomyocytes carrying an SCN5A mutation identify nitric oxide signaling as a mediator of atrial fibrillation.
Hong L; Zhang M; Ly OT; Chen H; Sridhar A; Lambers E; Chalazan B; Youn SW; Maienschein-Cline M; Feferman L; Ong SG; Wu JC; Rehman J; Darbar D
Stem Cell Reports; 2021 Jun; 16(6):1542-1554. PubMed ID: 34019817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
